- জেনেরিক নাম
- Nelfinavir
- শক্তি
- 250 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Delta Pharma Limited
Nelidel Tablet
Nelidel 250 mg Tablet সম্পর্কে
Nelidel 250 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Nelfinavir এবং শক্তি ২৫০ mg। Nelidel প্রস্তুত করেছে Delta Pharma Limited। Nelidel-এর সাথে Nelfinavir-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Nelfinavir-এর ২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।
Nelidel 250 mg Tablet কী?
Nelidel 250 mg is a tablet product of Delta Pharma Limited that contains Nelfinavir. Nelfinavir is a selective, competitive, reversible HIV protease inhibitor. Ask your doctor or pharmacist if you are unsure about it.
Nelidel-এর ব্যবহার
Nelfinavir is indicated for the treatment of HIV infection when antiretroviral therapy is warranted Ask your doctor whether it is right for your condition.
Nelidel কীভাবে ব্যবহার করবেন
Swallow the tablet with water. Nelidel is taken by mouth. If you are unsure how to take it, ask your doctor or pharmacist. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.
Nelidel-এর পার্শ্বপ্রতিক্রিয়া
The majority of adverse events were of mild intensity. General : Abdominal pain, accidental injury, allergic reaction, astheni The most frequently reported adverse event among patients receiving Nelfinavir was diarrhoea, which was generally of mild to moderate intensity. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
সতর্কতা ও নিরাপত্তা
Nelfinavir is contraindicated in patients with clinically significant hypersensitivity to any of its components. There are no adequate and well controlled studies in pregnant women. Lactation: The US Public Health Service Centers for Disease Control and Prevention advises HIV-infected women not to breast-feed to avoid postnatal transmission of HIV to a child. Ask your doctor first if any of these apply to you.
সাধারণ প্রশ্ন
What does Nelidel treat?
Nelfinavir is indicated for the treatment of HIV infection when antiretroviral therapy is warranted Ask your doctor whether it is right for your condition.
How is Nelidel used?
Swallow the tablet with water. Nelidel is taken by mouth.
Can Nelidel cause side effects?
The majority of adverse events were of mild intensity. General : Abdominal pain, accidental injury, allergic reaction, astheni The most frequently reported adverse event among patients receiving Nelfinavir was diarrhoea, which was generally of mild to moderate intensity.
Is Nelidel safe for everyone?
Nelfinavir is contraindicated in patients with clinically significant hypersensitivity to any of its components. There are no adequate and well controlled studies in pregnant women.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nelfinavir is indicated for the treatment of HIV infection when antiretroviral therapy is warrantedফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nelfinavir is a selective, competitive, reversible HIV protease inhibitor. It inhibits HIV-1 protease preventing the cleavage of the gag-pol polyprotein resulting in the production of noninfectious virus.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adults: The recommended dose is 1250 mg (five 250 mg tablets) twice daily or 750 mg (three 250 mg tablets) three times daily. Nelfinavir should be taken with a meal. Antiviral activity is enhanced when Nelfinavir is administered in combination with nucleoside analogues. Therefore, it is recommended that Nelfinavir should be used in combination with nucleoside analogues.Paediatric patients (2-13 years): The recommended oral dose of Nelfinavir for paediatric patients 2 to 13 years of age is 20-30 mg/kg per dose, three times daily with a meal.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Reduced levels/effects with antacids, phenobarbital, carbamazepine, aminoglutethimide, phenytoin, rifampicin, nafcillin, nevirapine, omeprazole, nevirapine. Increased serum levels/effects with azole antifungal agents, cimetidine, efavirenz. Increased serum levels/effects of azithromycin, calcium channel blockers, clarithromycin, corticosteroids (e.g. fluticasone), mirtazapine, nateglinide, nefazodone, ciclosporin, sirolimus, tacrolimus, venlafaxine, eplerinone, fentanyl, atorvastatin, phosphodiesterase-5 (PDE-5) inhibitors, rifabutin, trazodone, TCAs. Reduced serum levels/effects of hormonal contraceptives, methadone, theophylline derivatives.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nelfinavir is contraindicated in patients with clinically significant hypersensitivity to any of its components. Co-administration of Avifix is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening adverse eventsপার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The safety of Nelfinavir was studied in over 1500 patients who received drug either alone or in combination with nucleoside analogues. The majority of adverse events were of mild intensity. The most frequently reported adverse event among patients receiving Nelfinavir was diarrhoea, which was generally of mild to moderate intensity. Adverse events occurring in less than 2% of patients receiving Nelfinavir in all phase II/III clinical trials and considered at least possibly related or of unknown relationship to treatment and of at least moderate severity are listed below.General: Abdominal pain, accidental injury, allergic reaction, asthenia, back pain, fever, headache, malaise, pain and redistribution/accumulation of body fat.
Digestive system: Anorexia, dyspepsia, epigastric pain, gastrointestinal bleeding, hepatitis, mouth ulceration, pancreatitis and vomiting.
Haemic/Lymphatic system: Anaemia, leukopenia and thrombocytopenia.
Metabolic/Nutritional: Increase in alkaline phosphate, amylase, creatinine phosphokinase, lactic dehydrogenase, SGOT, SGPT and g glutamyl transpeptidase, hyperlipaemia, hyperuricaemia, hyperglycaemia, hypoglycaemia, dehydration and liver function tests abnormal.
Musculoskeletal system: Arthralgia, arthritis, cramps, myalgia, myasthenia and myopathy.
Nervous system: Anxiety, depression, dizziness, emotional lability, hyperkinesia, insomnia, migraine, paraesthesia, seizures, sleep disorder, somnolence and suicide ideation.
Respiratory system: Dyspnoea, pharyngitis, rhinitis and sinusitis.
Skin/Appendages: Dermatitis, folliculitis, fungal dermatitis, maculopapular rash, pruitus, sweating, and urticaria.
Ophthalmic: Acute iritis and eye disorder.
Urogenital system: Kidney calculas, sexual dysfunction.
গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category B. There are no adequate and well controlled studies in pregnant women.Lactation: The US Public Health Service Centers for Disease Control and Prevention advises HIV-infected women not to breast-feed to avoid postnatal transmission of HIV to a child.
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nelfinavir should not be administered concurrently with Terfenadine, Astemizole, Cisapride, Triazolam, Midazolam, Ergot derivatives, Amiodarone or Quinidine because Nelfinavir may affect the hepatic metabolism of these drugs and create potential for serious and/or life-threatening adverse events. New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus and hyperglycaemia have been reported during post-marketing surveillance in HIV-infected patients receiving protease inhibitor therapy. Some patients required either initiation or dose adjustments of insulin or oral hypoglycaemic agents for treatment of these events. In some cases diabetic ketoacidosis has occurred. In those patients who discontinued protease inhibitor therapy, hyperglycaemia persisted in some cases.General: Nelfinavir is principally metabolised by the liver. Therefore, caution should be exercised when administering this drug to patients with hepatic impairment.
Haemophilia: There have been reports of increased bleeding, including spontaneous skin haematomas and haemarthrosis, in patients with haemophilia type A and B treated with protease inhibitors. In some patients, additional factor VIII was given. In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced. A causal relationship has not been established.
বিকল্প ব্র্যান্ড: Nelfinavir
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।